Filing Flows › Kura Oncology (KURA) › Recalls, complaints & regulation

Kura Oncology (KURA): clinical trials

Kura Oncology (KURA) beyond its filings: 6 active clinical trials.

Kura Oncology's latest quarter

Kura Oncology, Q2 2026: revenue $20.9M (+36% year over year), operating margin -349.8%, net loss $68.3M, operating cash flow −$62.5M. The chart follows the revenue to costs, profit and cash.

Questions

How many clinical trials does Kura Oncology have?

6 active studies on ClinicalTrials.gov, 1 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.